1. Danish Council of Ethics Patenting Human Genes and Stem Cells. Danish Council of Ethics; Copenhagen: 2004.
2. The Nuffield Council on Bioethics The Ethics of Patenting DNA: A Discussion Paper. Nuffield Council of Bioethics; London: 2002.
3. Resnik DB. DNA Patents and Human Dignity. J.L. Med. & Ethics. 2001;29:152. [PubMed]
4. House of Commons, Standing Committee on Health Assisted Human Reproduction: Building Families. Ottawa: Government of Canada; 2001.
5. Williams-Jones B. History of a gene patent: tracing the development and application of commercial BRCA testing. Health Law J. 2002;10:123–146. [PubMed] 6. Kevles D, Berkowitz A. The Gene Patenting Controversy: A Convergence of Law, Economic Interests, and Ethics. Brooklyn L. Rev. 2001;67:233–248. [PubMed]
7. National Academy of Sciences Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health. National Academies Press; Washington, D.C.: 2005.
8. Heller M, Eisenberg R. Can patents deter innovation? The anticommons in biomedical research. Science. 1998;280:698–701. [PubMed]
9. Merges RP, Nelson RR. On the Complex Economics of Patent Scope. Columbia L. Rev. 1990;90:839–916.
10. Scotchmer S. Standing on the Shoulders of Giants: Cumulative Research and the Patent Law. J. Econ. Perspect. 1991;5:29–41.
11. Caulfield T. Policy Conflicts: Gene Patents and Health Care in Canada. Community Genet. 2005;8:223–227. [PubMed]
12. Nelson RR. The Market Economy and the Scientific Commons. Research Policy. 2004;33:455–471.
13. David PA. Can ‘Open Science’ be Protected from the Evolving Regime of IPR Protections? Journal of Theoretical and Institutional Economics. 2004;160:1–26.
14. Hahn L. Owning a piece of Jonathan. Chicago Magazine. 2003 May;
15. Ontario Ministry of Health Genetics, Testing and Gene Patenting: Charting New Territory in Healthcare. Toronto: Government of Ontario; 2002.
16. National Academy of Sciences A Patent System for the 21st Century. The National Academies Press; Washington, D.C.: 2004.
17. Cho M. Ethical and legal issues in the 21st century in preparing for the millennium. American Association for Clinical Chemistry (AACC) Newsletter. 1998:47–53.
18. Merz JF, Kriss AG, Leonard DGB, Cho MK. Diagnostic testing fails the test. Nature. 2002;415:577–579. [PMC free article] [PubMed]
19. Benzie R. Ontario to defy U.S. Patents on cancer genes. The National Post. 2001 Sept 20;:15. A.
20. Jensen K, Murray F. Enhanced: Intellectual Property Landscape of the Human Genome. Science. 2005;310:239–240. [PubMed] 21. Walsh JP, Cohen WM, Arora A. Working through the patent problem. Science. 2003;299:1020. [PubMed] 22. Walsh JP, Cho C, Cohen WM. View from the Bench: Patents and Material Transfers. Science. 2005;309:2002–2003. [PubMed]
23. Nicol D, Nielsen J. Patents and Medical Biotechnology: An Empirical Analysis of Issues Facing the Australian Industry - Occasional Paper No. 6. Centre for Law & Genetics; Sandy Bay, Australia: 2003.
24. Nagaoka S. An empirical analysis of patenting and licensing practices of research tools from three perspectives. Presentation to OECD Conference on Research Use of Patented Inventions; Madrid. May 18-19, 2006; 2006. http://www.oecd.org/dataoecd/20/54/36816178.pdf. 25. Straus J. Genetic Inventions and Patents — A German Empirical Study. presentation to the BMBF & OECD Workshop entitled “Genetic Inventions, Intellectual Property Rights and Licensing Practices”; Berlin. January 24-25, 2002; online: OECD <http:// http://www.oecd.org/dataoecd/36/22/1817995.pdf>.
26. Stern S, Murray FE. Do Formal Intellectual Property Rights Hinder the Free Flow of Scientific Knowledge? An Empirical Test of the Anti-Commons Hypothesis: NBER Working Paper No. W11465. 2005.
27. Sampat B. Unpublished manuscript. Columbia University, Department of Health Policy and Management; 2005. Do Academic Genomic Patents Curtail Downstream Research?
28. Cohen J. Chiron Stakes out its Territory. Science. 1999;285:28.
29. Walsh JP, Cohen WM, Arora A. Patenting and licensing of research tools and biomedical innovation. In: Cohen WM, Merrill S, editors. Patents in the Knowledge-Based Economy. NAP; Washington, DC: 2003.
30. Cho MK, et al. Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Services. J. Mol. Diag. 2003;5:3–8. [PubMed] 31. Blumenthal D, et al. Withholding Research Results in Academic Life Science: Evidence From a National Survey of Faculty. JAMA. 1997;277:1224. [PubMed] 32. Campbell EG, et al. Data withholding in academic genetics. JAMA. 2002;287:473–480. [PubMed] 33. Walsh JP, Hong W. Secrecy is increasing in step with competition. Nature. 2003;422:801–802. [PubMed]
34. Grushcow J. Measuring Secrecy: A Cost of the Patent System Revealed. Journal of Legal Studies. 2004;33:59–84.
35. Vogeli C, et al. Data Withholding and the Next Generation of Scientists: Results of a National Survey. Acad. Med. 2006;81(2):128–136. [PubMed] 36. Blumenthal D, et al. Data Withholding in Genetics and the Other Life Sciences: Prevalences and Predictors. Acad. Med. 2006;81(2):137. [PubMed]
37. Cohen WM, Florida R, Goe R. University-Industry Research Centers in the United States. Report to the Ford Foundation. Carnegie Mellon University; Pittsburgh: 1994.
38. Bekelman JE, Li Y, Gross GP. Scope and Impact of Financial Conflicts of Interst in Biomedical Research. JAMA. 2003;289(4):454–465. [PubMed]
39. Dasgupta P, Maskin E. The simple economics of research portfolios. Economic Journal. 1987;97:581–595.
40. Van Overwalle G, Van Zimmeren E. Reshaping Belgian Patent Law: The Revision of the Research Exemption and the Introduction of a Compulsory License for Public Health. Chizaiken Forum. 2006;64:42–49.
41. Kieff FS. Facilitating Scientific Research: Intellectual Property Rights and the Norms of Science - A Response to Rai & Eisenberg. Northwestern University L. Rev. 2001;95:691–706.
42. Pressman, et al. Patenting and Licensing Practices for DNA-Based Patents at U.S. Academic Institutions. Nat Biotech. 2005;24:31–39.
43. Eisenberg R. Patent Swords and Shields. Science. 2003;299:5609, 1018–9. [PubMed]
44. Rohrbaugh MI. NIH Best Practices Guidelines for Licensing Genomic Inventions. Fed. Regist. 2005;70(68):18413–18415.
45. Grimm D. A Mouse for Every Gene. Science. 2006;312:1862–1866. [PubMed]
46. Ravetz JR. Scientific Knowledge and its Social Problems. Oxford University Press; New York: 1973.
47. Canadian Biotechnology Advisory Committee Human Genetic Materials, Intellectual Property and the Health Sector. CBAC; Ottawa: 2006.
48. World Health Organization Public Health Innovation and Intellectual Property Rights. WHO Press; Geneva, Switzerland: 2006. [PubMed]
49. Australian Government Advisory Committee on Intellectual Property Patents and Experimental Use. Sydney: ACIP; 2005.
50. Canadian Biotechnology Advisory Committee Expert Working Party on Human Genetic Materials, Intellectual Property and the Health Sector Human Genetics Materials: Making Canada’s Intellectual Property Regime Work for the Health of Canadians. CBAC; Ottawa: 2005.
51. National Research Council Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation and Public Health. National Academies Press; Washington, D.C.: 2005. [PubMed]
52. World Health Organization Genetics, genomics and the patenting of DNA: Review of potential implications for health in developing countries. WHO Press; Geneva, Switzerland: 2005.
53. Australian Law Reform Commission Report 99 - Genes and Ingenuity: Gene Patenting and Human Health. SOS Printing Group; Sydney: 2004.
54. Federal Trade Commission To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy. FTC; Washington, D.C.: 2003.
55. The Royal Society Keeping Science Open: The Effects of Intellectual Property Policy on the Conduct of Science. TRS; London: 2003.
56. Public Health Genetics Unit, Cambridge Intellectual Property Rights (IPRs) and Genetics. PHGU; Cambridge: 2003.
57. Organization for Economic Co-operation and Development Genetic Inventions, Intellectual Property Rights & Licensing Practices. OECD Publications; Paris: 2002.
58. Canadian Biotechnology Advisory Committee Patenting of Higher Life Forms and Related Issues. CBAC; Ottawa: 2002.